Home NDC 48102-028 Avaclyr
Product NDC 48102-028
11-digit product format 481020028
Labeler code 48102
Product ID 48102-028_b0fc154b-dce6-4302-a59b-68fcf4d6e022
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ACYCLOVIR
Dosage form OINTMENT
Route OPHTHALMIC
Labeler Fera Pharmaceuticals, LLC
Application NDA202408
Marketing category NDA
Marketing start 2026-01-31
Substance ACYCLOVIR
Active strength 30 mg/g
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N202408-001 AVACLYR ACYCLOVIR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N202408-001 ODE-235 2026-03-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N202408-001 AVACLYR 3% OINTMENT / OPHTHALMIC RLD 2019-03-29 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N202408-001 AVACLYR 3% OINTMENT / OPHTHALMIC RLD 2019-03-29 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N202408-001 AVACLYR 3% OINTMENT / OPHTHALMIC RLD 2019-03-29 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N202408-001 AVACLYR 3% OINTMENT / OPHTHALMIC RLD 2019-03-29 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N202408-001 AVACLYR 3% OINTMENT / OPHTHALMIC RLD 2019-03-29 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N202408-001 AVACLYR 3% OINTMENT / OPHTHALMIC RLD 2019-03-29 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N202408-001 AVACLYR 3% OINTMENT / OPHTHALMIC RLD 2019-03-29 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N202408-001 AVACLYR 3% OINTMENT / OPHTHALMIC RLD 2019-03-29 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N202408-001 AVACLYR 3% OINTMENT / OPHTHALMIC RLD 2019-03-29 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N202408-001 AVACLYR 3% OINTMENT / OPHTHALMIC RLD, RS 2019-03-29 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N202408-001 AVACLYR 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** OINTMENT / OPHTHALMIC RLD 2019-03-29 f41ea6bd6efb…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 43 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Avaclyr
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR 30 mg/g
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 48102-028-35 Avaclyr 3.5 g in 1 TUBE OINTMENT 3.5 3 48102-028-35 Avaclyr 1 in 1 CARTON OINTMENT 1 3
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 48102-028-35 48102002835 1 TUBE in 1 CARTON (48102-028-35) / 3.5 g in 1 TUBE 1 tube 2026-01-31 No No Current